Spatially Resolved Sequential Activation of Allosteric DNA for In Vivo Dual-Target Detection within Mitochondria: A Strategy to Visualize of Drug-Resistant Neuroblastoma
ACS Sensors · 2026
DOI: 10.1021/acssensors.5c04083 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, 2026. Verfasst von Jingzhe Zang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Henan Key Laboratory of Genetic and Deve…. Hauptthemen laut MEDLINE: Neuroblastoma, Drug Resistance, Neoplasm, DNA, Mitochondria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Henan Medical Science and Technique Foundation, National Natural Science Foundation of China, Henan Provincial Science and Technology Research Project.
Abstract (Originalsprache)
Our previous study demonstrated that apurinic/apyrimidinic endonuclease 1 (APE1) and miR-514a are significantly overexpressed in the cytoplasm of drug-resistant neuroblastoma (NB) cells. Furthermore, we have developed a novel strategy for monitoring drug resistance in NB by targeting cytoplasmic APE1 and miR-514a. The overexpression of key enzymes in the mitochondrial base excision repair pathway, along with dysregulated miRNAs, is closely associated with chemotherapy resistance in tumors. Therefore, this study leverages cytochrome c (cyt c), located in the inner mitochondrial membrane as a targeting agent and the mitochondria-specific expression of 16S rRNA as a response switch to develop a spatially resolved, sequential activation system for an allosteric DNA nanomachine (AP-miR-tFNA), enabling in vivo detection of APE1 and miR-514a within mitochondria and facilitating molecular imaging of NB. AP-miR-tFNA sequentially responds to cyt c, 16S rRNA, miR-514a, and APE1, thereby undergoing a conformational change that efficiently achieves progressive dissociation of the fluorophore from the quencher through a sequential mechanism, ultimately generating a detectable fluorescence signal. Experimental results demonstrate that AP-miR-tFNA enables in vivo monitoring of drug resistance in NB, providing an innovative and dependable approach for monitoring therapeutic resistance in NB. In particular, AP-miR-tFNA enables in situ detection of APE1 and miR-514a within NB plasma exosomes, thereby allowing non-invasive differentiation between high-risk and low-to-intermediate-risk NB, as well as between drug-resistant NB and non-drug-resistant NB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Henan Key Laboratory of Genetic and Developmental Disorders, Henan International Joint Laboratory for Preventi…
- Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China.
- NMPA Key Laboratory for Quality Control of In Vitro Diagnostics Foundation, NMPA Key Laboratory for Quality Evaluation of Medical Protective and Implant Devices, Henan Institute for Drug and Medical Device Inspection (H…
ORCID-Profile: Wancun Zhang
Förderung
- Henan Medical Science and Technique Foundation
- National Natural Science Foundation of China
- Henan Provincial Science and Technology Research Project
- Henan provincial clinical medical research center for pediatric diseases
- MPA key laboratory for quality evaluation of medical protective and implant devices foundation
- NMPA key laboratory for quality control of in vitro diagnostics foundation
- Research on the High-Quality Development of the Medical Device Industry in Henan province
Zitieren
APA
Zang, J., Zhang, Y., Liu, K., Xu, Y., Zhao, L., Wang, W., Zhang, M., Qin, X., Wang, Q., Zhang, X., & Zhang, W. (2026). Spatially Resolved Sequential Activation of Allosteric DNA for In Vivo Dual-Target Detection within Mitochondria: A Strategy to Visualize of Drug-Resistant Neuroblastoma. ACS Sensors. https://doi.org/10.1021/acssensors.5c04083
Vancouver
Zang J, Zhang Y, Liu K, Xu Y, Zhao L, Wang W, et al. Spatially Resolved Sequential Activation of Allosteric DNA for In Vivo Dual-Target Detection within Mitochondria: A Strategy to Visualize of Drug-Resistant Neuroblastoma. ACS Sensors. 2026. doi:10.1021/acssensors.5c04083
BibTeX
@article{Zang2026,
author = {Zang, Jingzhe and Zhang, Yingyu and Liu, Kangbo and Xu, Yuyin and Zhao, Liang and Wang, Wentao and Zhang, Mengxin and Qin, Xueyi and Wang, Qionglin and Zhang, Xianwei and Zhang, Wancun},
title = {Spatially Resolved Sequential Activation of Allosteric DNA for In Vivo Dual-Target Detection within Mitochondria: A Strategy to Visualize of Drug-Resistant Neuroblastoma},
journal = {ACS Sensors},
year = {2026},
doi = {10.1021/acssensors.5c04083}
}
EUVIMED